Search

Your search keyword '"Chaitman, Bernard R."' showing total 1,072 results

Search Constraints

Start Over You searched for: Author "Chaitman, Bernard R." Remove constraint Author: "Chaitman, Bernard R."
1,072 results on '"Chaitman, Bernard R."'

Search Results

2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

3. Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial

4. Impact of Complete Revascularization in the ISCHEMIA Trial

5. Myocardial Infarction in the ISCHEMIA Trial

6. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial

7. Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial

8. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

9. Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions — proceedings from the CEC Summit 2018

10. Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia: A Target Trial Emulation Using MINT Trial Data.

11. Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.

12. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial

13. Comparative Prognostic Utility of Coronary CT and Invasive Angiography

15. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease : Insights From the ISCHEMIA Trial

18. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

19. Outcomes of Participants with Diabetes in the ISCHEMIA Trials

21. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

25. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

26. The QT interval and risk of incident atrial fibrillation

28. LB-2 | VEGF Gene Therapy Improves Exercise Time, Ischemia, and Symptoms in Patients with Refractory Angina: Results of the Phase II EXACT Trial

29. Abstract 13030: Causes of Cardiovascular and Non-cardiovascular Mortality in the Ischemia Trial

30. Exercise Testing

32. Survival After Invasive or Conservative Management of Stable Coronary Disease

33. Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial

36. Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program

37. Assessment of the 12-Lead Electrocardiogram as a Screening Test for Detection of Cardiovascular Disease in Healthy General Populations of Young People (12–25 Years of Age): A Scientific Statement From the American Heart Association and the American College of Cardiology

39. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.

40. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

41. Exercise Testing

42. Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial

43. Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients: A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)

45. Clinical events classification (CEC) in clinical trials:Report on the current landscape and future directions — proceedings from the CEC Summit 2018

48. Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)

49. RELATIONSHIP OF HEALTH STATUS TO ISCHEMIA AND CORONARY ANATOMY IN THE ISCHEMIA TRIAL

Catalog

Books, media, physical & digital resources